ImmuCell Operating Expenses 2010-2025 | ICCC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

ImmuCell operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

ImmuCell operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$232.4B
Boston Scientific (BSX)	$153.7B
Stryker (SYK)	$150.7B
EssilorLuxottica (ESLOY)	$135.2B
Medtronic (MDT)	$114.7B
Lonza Group Ag (LZAGY)	$51.4B
Haleon (HLN)	$45.4B
ResMed (RMD)	$37.8B
Agilent Technologies (A)	$35.3B
GE HealthCare Technologies (GEHC)	$35B
Terumo (TRUMY)	$24.7B
Koninklijke Philips (PHG)	$23.7B
Insulet (PODD)	$20.9B
Zimmer Biomet Holdings (ZBH)	$18.8B
Baxter (BAX)	$15.2B
Smith & Nephew SNATS (SNN)	$13.6B
Demant (WILYY)	$9B
Sunny Optical Technology (SNPTF)	$8.6B
Bio-Rad Laboratories (BIO)	$7.1B
Lantheus Holdings (LNTH)	$5.8B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.8B
Perrigo (PRGO)	$3.7B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.4B
QuidelOrtho (QDEL)	$2.1B
LeMaitre Vascular (LMAT)	$1.9B
AtriCure (ATRC)	$1.6B
Acuren (TIC)	$1.4B